respiratory syncytial virus

A vaccine from GlaxoSmithKline showed the potential to protect adults ages 50 to 59 from respiratory syncytial virus in a late-stage clinical trial, the company said Wednesday.The initial…

A doctor vaccinates an infant against respiratory syncytial virus (RSV) in a treatment room of her paediatric practice.Swen Pförtner | Picture Alliance | Getty ImagesThe Centers for Disease…

By LAURAN NEERGAARD - AP Medical Writer WASHINGTON (AP) — Updated COVID-19 vaccines are coming soon, just in time to pair them with flu shots.…

By LAURAN NEERGAARD - AP Medical Writer WASHINGTON (AP) — U.S. regulators on Monday approved the first RSV vaccine for pregnant women so their…

The U.S. Food and Drug Administration on Monday approved Pfizer's respiratory syncytial virus (RSV) vaccine for use in women during the middle of the third trimester of pregnancy to…

Budrul Chukrut | Lightrocket | Getty ImagesGlaxoSmithKline CEO Emma Walmsley on Wednesday said she expects uptake for the company's new RSV vaccine to start off slower than it did for its…

Respiratory syncytial virus vial.Manjurul | Istock | Getty ImagesThe Centers for Disease Control and Prevention on Thursday recommended that adults ages 60 and above receive a single dose of…

Respiratory syncytial virus vial.Manjurul | Istock | Getty ImagesVaccinating one million adults ages 65 and above with a single RSV shot from Pfizer or GSK may prevent thousands of…

A health worker prepares a flu vaccine shot before administering it to a local resident in Los Angeles, the United States, on Dec. 17, 2022.Xinhua News Agency | Getty ImagesAn advisory…

Respiratory syncytial virus viral vaccine under research.Hailshadow | Istock | Getty ImagesGlaxoSmithKline on Wednesday said its vaccine to protect adults ages 60 and older from respiratory…